Department of Physiological Sciences, State University of Londrina, Londrina, PR, Brazil.
Department of Histology, State University of Londrina, Londrina, Brazil.
Physiol Behav. 2019 Oct 1;209:112587. doi: 10.1016/j.physbeh.2019.112587. Epub 2019 Jun 24.
Glucocorticoids (GC) increase food intake and body weight in humans and rodents and chronic stress and GC treatment-induced enhancement of the plasma concentration of GC lead to obesity and metabolic changes. In response to hypercaloric treatment, males were shown to be more susceptible to obesity than females, demonstrating that sex differences may affect energy homeostasis. The objective of the current study was to evaluate the effects of prolonged (28 days) treatment with dexamethasone or corticosterone on food intake and body weight gain in intact rats, both male and female. Also examined were Lee index, weights and area of adipocytes of retroperitoneal and perigonadal+perirenal adipose tissues, glucose tolerance test (GTT) and plasma concentrations of free fatty acids, cholesterol and triglycerides. Treatment with dexamethasone was able to increase body weight, food intake, area of adipocytes and weight of retroperitoneal adipose tissue in males. Prolonged treatment with corticosterone also stimulated body weight gain and food intake in males. In addition, it induced an increase in the area of adipocytes and weight of perirenal+perigonadal adipose tissue and higher glycemia after GTT in these animals, without changes on Lee index and plasma parameters after both GC treatments. No parameter was changed by dexamethasone or corticosterone treatment in female rats. Thus, it can be concluded that male rats are more susceptible to the anabolic effects of glucocorticoids than female rats, and these responses can be due to the protective effects of circulating estrogens in females, and/or the difference between males and females in the expression/activity of corticosteroids receptors.
糖皮质激素(GC)可增加人类和啮齿动物的食物摄入量和体重,慢性应激和 GC 治疗引起的 GC 血浆浓度升高可导致肥胖和代谢变化。在应对高热量处理时,雄性比雌性更容易肥胖,这表明性别差异可能会影响能量平衡。本研究的目的是评估长期(28 天)给予地塞米松或皮质酮对完整雄性和雌性大鼠的食物摄入量和体重增加的影响。还检查了 Lee 指数、腹膜后和性腺旁+肾周脂肪组织的脂肪细胞重量和面积、葡萄糖耐量试验(GTT)以及游离脂肪酸、胆固醇和甘油三酯的血浆浓度。地塞米松治疗可增加雄性大鼠的体重、食物摄入量、脂肪细胞面积和腹膜后脂肪组织重量。长期给予皮质酮也可刺激雄性大鼠的体重增加和食物摄入。此外,它还可诱导这些动物的肾周+性腺旁脂肪组织的脂肪细胞面积和重量增加以及 GTT 后的血糖升高,而两种 GC 处理后 Lee 指数和血浆参数均无变化。地塞米松或皮质酮治疗未改变雌性大鼠的任何参数。因此,可以得出结论,雄性大鼠比雌性大鼠更容易受到糖皮质激素的合成代谢作用的影响,这些反应可能是由于循环雌激素对雌性的保护作用,以及/或雄性和雌性之间皮质激素受体的表达/活性的差异所致。